* Evolent Health Inc EVH.N reported quarterly adjusted
earnings
of 23 cents per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of 10 cents. The mean expectation of
thirteen analysts for the quarter was for earnings of 15 cents
per share. Wall Street expected results to range from 1 cents
to 30 cents per share.
* Revenue rose 45.4% to $556.06 million from a year ago;
analysts
expected $542.40 million.
* Evolent Health Inc's reported EPS for the quarter was a
loss
of 36 cents.
* The company reported a quarterly loss of $41.4 million.
* Evolent Health Inc shares had fallen by 9.9% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 4.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Evolent Health
Inc is $43.50
This summary was machine generated from LSEG data February 23 at
12:26 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 0.15 0.23 Beat
Sep. 30 2023 0.07 0.30 Beat
Jun. 30 2023 0.11 0.14 Beat
Mar. 31 2023 0.20 0.21 Beat